The United States Nucleic Acid Therapeutics Market accounts for the largest share of the regional industry, supported by substantial investments in biotechnology innovation, advanced healthcare infrastructure, and a strong pipeline of nucleic acid-based therapies. Increasing prevalence of genetic disorders, cancer, and infectious diseases is driving the demand for RNA therapeutics, antisense...